R. Gounot

Anti-SARS-CoV-2 antibody response after 2 and 3 doses of BNT162b2 mRNA vaccine in patients with lymphoid malignancies

F. Lemonnier, C. Haioun, S. Gallien, 2022, Clinical Microbiology and Infection.

Venetoclax induces profound and sustained responses in patients with relapsed/refractory light‐chain amyloidosis

F. Lemonnier, C. Haioun, A. Maarek, 2021, British journal of haematology.

Daratumumab is safe and induces a rapid hematological response in light-chain amyloidosis with severe cardiac impairment

F. Lemonnier, C. Haioun, A. Maarek, 2020, Leukemia & lymphoma.